NVO
Novo Nordisk A/S
Company Overview
| Mkt Cap | $232.40B | Price | $49.46 |
| Volume | 20.02M | Change | -1.16% |
| P/E Ratio | 2.3 | Open | $48.78 |
| Revenue | $290.4B | Prev Close | $50.04 |
| Net Income | $101.0B | 52W Range | $45.05 - $112.52 |
| Div Yield | 1.17% | Target | $60.14 |
| Overall | 45 | Value | 60 |
| Quality | -- | Technical | 30 |
No chart data available
Stock Overview
Updated DailyNovo Nordisk A/S (NVO) is a leading Healthcare company in the Biotechnology industry, currently trading at $49.46 with a market capitalization of $232.40 billion. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows NVO with a volume of 20.02 million shares. The stock opened down 2.52% from yesterday's close of $50.04. Current analyst estimates project earnings of $3.66 per share for this year, with next year targeting $3.91.
NVO demonstrates concerning technical signals based on technical analysis. The company trades on the NYE exchange and operates alongside industry peers including PFE, BMY, LLY, SNY, RHHBY.
Key investment considerations for NVO include below-average investment characteristics. The company offers a dividend yield of 1.169632% and analyst price targets suggest potential upside of 21.6%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 2, 2025 at 02:31 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NVO | $49.46 | -1.2% | 20.02M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |